1. Home
  2. SABS vs TRVG Comparison

SABS vs TRVG Comparison

Compare SABS & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.86

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.92

Market Cap

211.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABS
TRVG
Founded
2014
2005
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
201.4M
211.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SABS
TRVG
Price
$3.86
$2.92
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$9.80
$4.09
AVG Volume (30 Days)
784.4K
27.1K
Earning Date
05-08-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.59
Revenue Next Year
N/A
$8.42
P/E Ratio
N/A
$16.98
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$2.63
52 Week High
$6.60
$5.83

Technical Indicators

Market Signals
Indicator
SABS
TRVG
Relative Strength Index (RSI) 48.41 55.52
Support Level $3.69 $2.74
Resistance Level $4.16 $2.96
Average True Range (ATR) 0.19 0.11
MACD -0.01 0.01
Stochastic Oscillator 29.69 87.88

Price Performance

Historical Comparison
SABS
TRVG

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

Share on Social Networks: